Integer Holdings Co. (NYSE:ITGR) Stock Holdings Lessened by Victory Capital Management Inc.

Victory Capital Management Inc. lessened its holdings in shares of Integer Holdings Co. (NYSE:ITGR - Free Report) by 19.1% in the third quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 627,886 shares of the medical equipment provider's stock after selling 148,003 shares during the quarter. Victory Capital Management Inc. owned 1.87% of Integer worth $81,625,000 as of its most recent filing with the SEC.

Other hedge funds have also recently bought and sold shares of the company. Contravisory Investment Management Inc. boosted its position in shares of Integer by 55.9% in the third quarter. Contravisory Investment Management Inc. now owns 223 shares of the medical equipment provider's stock worth $29,000 after buying an additional 80 shares during the period. Quest Partners LLC grew its position in Integer by 3,688.9% in the second quarter. Quest Partners LLC now owns 341 shares of the medical equipment provider's stock valued at $39,000 after acquiring an additional 332 shares in the last quarter. GAMMA Investing LLC grew its position in Integer by 60.9% in the second quarter. GAMMA Investing LLC now owns 375 shares of the medical equipment provider's stock valued at $43,000 after acquiring an additional 142 shares in the last quarter. Headlands Technologies LLC purchased a new stake in shares of Integer during the first quarter valued at approximately $106,000. Finally, Innealta Capital LLC acquired a new position in shares of Integer during the second quarter worth $110,000. Hedge funds and other institutional investors own 99.29% of the company's stock.

Integer Price Performance

Shares of NYSE:ITGR traded down $2.66 during trading on Thursday, reaching $134.91. The company had a trading volume of 225,726 shares, compared to its average volume of 310,768. Integer Holdings Co. has a twelve month low of $84.75 and a twelve month high of $140.91. The company has a debt-to-equity ratio of 0.67, a quick ratio of 2.09 and a current ratio of 3.28. The firm has a market capitalization of $4.52 billion, a PE ratio of 42.15, a price-to-earnings-growth ratio of 1.97 and a beta of 1.09. The firm's fifty day moving average is $129.02 and its 200 day moving average is $122.37.

Integer (NYSE:ITGR - Get Free Report) last issued its quarterly earnings results on Thursday, October 24th. The medical equipment provider reported $1.43 EPS for the quarter, topping the consensus estimate of $1.36 by $0.07. The firm had revenue of $431.42 million for the quarter, compared to analysts' expectations of $440.59 million. Integer had a net margin of 6.70% and a return on equity of 11.63%. Integer's revenue for the quarter was up 8.7% compared to the same quarter last year. During the same period in the previous year, the business earned $1.27 earnings per share. On average, equities analysts forecast that Integer Holdings Co. will post 5.33 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on ITGR shares. Bank of America lifted their target price on Integer from $135.00 to $145.00 and gave the stock a "buy" rating in a research report on Tuesday, October 1st. Piper Sandler reaffirmed an "overweight" rating and issued a $140.00 price target (up from $125.00) on shares of Integer in a report on Friday, October 25th. Truist Financial lowered their price objective on Integer from $150.00 to $147.00 and set a "buy" rating for the company in a research note on Friday, October 25th. KeyCorp upped their price target on shares of Integer from $139.00 to $144.00 and gave the stock an "overweight" rating in a research report on Tuesday, October 15th. Finally, Benchmark upped their target price on shares of Integer from $130.00 to $140.00 and gave the stock a "buy" rating in a research report on Monday, October 21st. One equities research analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat.com, Integer has a consensus rating of "Moderate Buy" and a consensus price target of $139.75.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.